{"rows":[{"id":2344,"title":"Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.","authors":"Sakloth F, Leggett E, Moerke MJ, Townsend EA, Banks ML, Negus SS","journal":"Experimental and clinical psychopharmacology","publication_date":"2019-06-01","publication_year":2019,"doi":"10.1037/pha0000253","pubmed_id":"30628811","openalex_id":"https://openalex.org/W2909121609","source_url":"https://pubmed.ncbi.nlm.nih.gov/30628811/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Receptor Pharmacology,Microdosing,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:30628811","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/30628811/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:30628811","source_url":"https://pubmed.ncbi.nlm.nih.gov/30628811/","doi":"10.1037/pha0000253","pmid":"30628811","publication_date":"2019-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1901,"title":"Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.","authors":"Fogg C, Michaels TI, de la Salle S, Jahn ZW, Williams MT","journal":"Experimental and clinical psychopharmacology","publication_date":"2021-10-01","publication_year":2021,"doi":"10.1037/pha0000490","pubmed_id":"34096755","openalex_id":"https://openalex.org/W3171546624","source_url":"https://pubmed.ncbi.nlm.nih.gov/34096755/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Pharmacology,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:06","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:34096755","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34096755/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34096755","source_url":"https://pubmed.ncbi.nlm.nih.gov/34096755/","doi":"10.1037/pha0000490","pmid":"34096755","publication_date":"2021-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1801,"title":"Verbal behavior related to drug reinforcement in polysubstance cannabis users: Comparison across drugs.","authors":"Cox DJ, Johnson MW","journal":"Experimental and clinical psychopharmacology","publication_date":"2022-04-01","publication_year":2022,"doi":"10.1037/pha0000404","pubmed_id":"34291991","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/34291991/","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Healthcare Workers","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:20","bibtex":null,"source_record_id":"PMID:34291991","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34291991/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34291991","source_url":"https://pubmed.ncbi.nlm.nih.gov/34291991/","doi":"10.1037/pha0000404","pmid":"34291991","publication_date":"2022-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1521,"title":"To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.","authors":"Christensen JA, Fipps DC, Bostwick JM","journal":"Experimental and clinical psychopharmacology","publication_date":"2023-04-01","publication_year":2023,"doi":"10.1037/pha0000597","pubmed_id":"36048112","openalex_id":"https://openalex.org/W4294127245","source_url":"https://pubmed.ncbi.nlm.nih.gov/36048112/","substance_tags":"psilocybin","topic_tags":"Addiction,Brain Imaging,Review Article,Safety","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:16","bibtex":null,"source_record_id":"PMID:36048112","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36048112/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36048112","source_url":"https://pubmed.ncbi.nlm.nih.gov/36048112/","doi":"10.1037/pha0000597","pmid":"36048112","publication_date":"2023-04-01","importer_version":"2.1.3","text_redistributed":false}}],"total":4,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Experimental and clinical psychopharmacology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}